Advancing Effective Mental Healthcare: Grow Therapy Raises $88 Million
2 minute read | April.11.2024
Grow Therapy, a provider-centric tech company improving access to high-quality mental healthcare, has closed an $88 million funding round.
2 minute read | April.11.2024
Grow Therapy, a provider-centric tech company improving access to high-quality mental healthcare, has closed an $88 million funding round.
2 minute read | April.10.2024
Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.
2 minute read | April.10.2024
First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, has acquired ImmunogenX in an all-stock transaction.
2 minute read | January.17.2024
by Irena Royzman Ph.D. and Lauren Drake
5 minute read | May.22.2024
The Supreme Court should reverse a decision on statutory patent term guarantees for Patent Office delays, Orrick’s Irena Royzman and Lauren Drake say.
by Thora Johnson and Peter Graham
2 minute read | May.01.2024
Legislators in Colorado have passed the first law in the United States meant to protect a consumer’s brainwaves.
by Thora Johnson and Cosmas Robless
7 minute read | April.30.2024
25 minute read | February.26.2024
Women's & Reproductive Health
by Stephen Thau, Albert Vanderlaan and George Pothoulakis
6 minute read | January.30.2024
Reverse mergers have helped biotech companies access public markets, but recent SEC positions are threatening that path to going public.
by David Rhinesmith, Thora Johnson, Stephen Thau and Tony Chan
4 minute read | November.10.2023
22 minute read | November.10.2023
2 minute read | April.15.2024
1 minute read | March.11.2024
3 minute read | January.31.2024
David Sharrow joins the firm’s life sciences and tech transactions team as a partner.
2 minute read | January.24.2024
Timothy Carroll joins Orrick's IP litigation practice as a partner in Chicago and Washington, D.C.
2 minute read | February.20.2024
2 minute read | December.05.2023
On Thursday, May 16, 2024, Intellectual Property partner Irena Royzman will lead a presentation titled "Mandatory Clinical Trial Disclosures as Prior Art" at NJIPLA's 2024 Patent Litigation Seminar.